Literature DB >> 30603862

The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN.

Rachel E Simpson1, Eugene P Ceppa1,2, Howard H Wu3, Fatih Akisik4, Michael G House1, Nicholas J Zyromski1, Attila Nakeeb1, Mohammad A Al-Haddad2,5, John M DeWitt5, Stuart Sherman5, C Max Schmidt6,7,8,9,10.   

Abstract

OBJECTIVE(S): A dilated main pancreatic duct in the distal remnant after proximal pancreatectomy for intraductal papillary mucinous neoplasms (IPMN) poses a diagnostic dilemma. We sought to determine parameters predictive of remnant main-duct IPMN and malignancy during surveillance.
METHODS: Three hundred seventeen patients underwent proximal pancreatectomy for IPMN (Indiana University, 1991-2016). Main-duct dilation included those ≥ 5 mm or "dilated" on radiographic reports. Statistics compared groups using Student's T/Mann-Whitney U tests for continuous variables or chi-square/Fisher's exact test for categorical variables with P < 0.05 considered significant.
RESULTS: High-grade/invasive IPMN or adenocarcinoma at proximal pancreatectomy predicted malignant outcomes (100.0% malignant outcomes; P < 0.001) in remnant surveillance. Low/moderate-grade lesions revealed benign outcomes at last surveillance regardless of duct diameter. Twenty of 21 patients undergoing distal remnant reoperation had a dilated main duct. Seven had main-duct IPMN on remnant pathology; these patients had greater mean maximum main-duct diameter prior to reoperation (9.5 vs 6.2 mm, P = 0.072), but this did not reach statistical significance. Several features showed high sensitivity/specificity for remnant main-duct IPMN.
CONCLUSIONS: Remnant main-duct dilation after proximal pancreatectomy for IPMN remains a diagnostic dilemma. Several parameters show a promise in accurately diagnosing main-duct IPMN in the remnant.

Entities:  

Keywords:  Mucinous neoplasms; Pancreatic cyst; Pancreatic duct; Pancreatic neoplasms; Pancreaticoduodenectomy

Year:  2019        PMID: 30603862     DOI: 10.1007/s11605-018-4026-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  45 in total

1.  The transduodenal rendezvous: a new approach to deeply cannulate the main pancreatic duct.

Authors:  J M Dumonceau; M Cremer; M Baize; J Devière
Journal:  Gastrointest Endosc       Date:  1999-08       Impact factor: 9.427

2.  A new application for therapeutic EUS: main pancreatic duct drainage with a "pancreatic rendezvous technique".

Authors:  Laurent Bataille; Pierre Deprez
Journal:  Gastrointest Endosc       Date:  2002-05       Impact factor: 9.427

3.  Clinical presentation of mucin-secreting tumors of the pancreas.

Authors:  F Tibayan; M Vierra; B Mindelzun; D Tsang; J McClenathan; H Young; H W Trueblood
Journal:  Am J Surg       Date:  2000-05       Impact factor: 2.565

Review 4.  Cystic neoplasms of the pancreas.

Authors:  William R Brugge; Gregory Y Lauwers; Dushyant Sahani; Carlos Fernandez-del Castillo; Andrew L Warshaw
Journal:  N Engl J Med       Date:  2004-09-16       Impact factor: 91.245

Review 5.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

6.  The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology.

Authors:  Asif Khalid; Kevin M McGrath; Maliha Zahid; Matt Wilson; Debra Brody; Patricia Swalsky; Arthur J Moser; Kenneth K Lee; Adam Slivka; David C Whitcomb; Sydney Finkelstein
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

7.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

8.  EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: Report of 6 cases.

Authors:  Shawn Mallery; Jake Matlock; Martin L Freeman
Journal:  Gastrointest Endosc       Date:  2004-01       Impact factor: 9.427

9.  Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas.

Authors:  Yuichi Kitagawa; Trisha A Unger; Shari Taylor; Richard A Kozarek; L William Traverso
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

10.  Repeated pancreatectomy after pancreatoduodenectomy.

Authors:  Fumihiko Miura; Tadahiro Takada; Hodaka Amano; Masahiro Yoshida; Takahiro Isaka; Naoyuki Toyota; Keita Wada; Kenji Takagi; Kenichoro Kato
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

View more
  1 in total

1.  Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy?

Authors:  Alex B Blair; Ross M Beckman; Joseph R Habib; James F Griffin; Kelly Lafaro; Richard A Burkhart; William Burns; Matthew J Weiss; John L Cameron; Christopher L Wolfgang; Jin He
Journal:  HPB (Oxford)       Date:  2021-09-23       Impact factor: 3.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.